Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Rangering i aksjer #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Aksjekurs
$3.78
Sist synkronisert: 2026-03-17
Markedsverdi
$276.54M
Endring (1 dag)
0.00%
Endring (1 år)
45.53%
Land
CA
Handel NervGen Pharma Corp. (NGEN)

Kategori

Aksjeprishistorikk for NervGen Pharma Corp. (NGEN)
Høyeste sluttskurs: $3.98 den 2026-03-01

Laveste sluttskurs: $1.12 den 2019-03-01
Aksjeprishistorikk for NervGen Pharma Corp. fra 2019 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.24 -10.01%
AU
$748.60 6.90%
CH